⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8844627 | 0.82 | FFAR3 (0.50) | — | |
| SCHEMBL63051 | 0.80 | — | — | |
| SCHEMBL16104630 | 0.80 | — | — | |
| SCHEMBL28186481 | 0.78 | TSHR (0.42) | — | |
| Hydrochloric Acid SCHEMBL11709036 | 0.78 | LMNA (0.46) | — | |
| SCHEMBL5554876 | 0.78 | TSHR (0.42) | — | |
| SCHEMBL28187226 | 0.78 | TSHR (0.42) | — | |
| SCHEMBL1501506 | 0.76 | LMNA (0.38) | — | |
| SCHEMBL11142565 | 0.76 | LMNA (0.38) | — | |
| SCHEMBL8531618 | 0.75 | LMNA (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117898961-A | Application of alkyl phosphine compound in preparation of cosmetics | 合肥博思科创医药科技有限公司 | 2024-04-19 | — | — | CN | claimed |
| US-20250313572-A1 | MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE | ABBVIE INC (US) | 2025-10-09 | — | — | US | disclosed |
| US-20240228509-A1 | MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE | ABBVIE INC (US) | 2024-07-11 | — | — | US | disclosed |
| CN-117898961-A | Application of alkyl phosphine compound in preparation of cosmetics | 合肥博思科创医药科技有限公司 | 2024-04-19 | — | — | CN | disclosed |
| US-20230399340-A1 | MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE | ABBVIE INC (US) | 2023-12-14 | — | — | US | disclosed |
| US-20200239494-A1 | MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE | ABBVIE INC (US) | 2020-07-30 | — | — | US | disclosed |
| EP-3668502-A1 | MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE | AbbVie Inc. (US) | 2020-06-24 | — | — | EP | disclosed |
| WO-2019035927-A1 | MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE | ABBVIE INC. (US) | 2019-02-21 | — | — | WO | disclosed |
| US-5104985-A | Rearrangement in the presence of an alkali metal bis (tris-lower alkyl silyl)amide | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1992-04-14 | — | — | US | disclosed |
| EP-0193132-B1 | LABDAN-DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1991-04-17 | — | — | EP | disclosed |
| US-4963537-A | REDUCE INTRAOCULAR PRESSURE | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1990-10-16 | — | — | US | disclosed |
| US-4851397-A | LOWERING INTRAOCULAR PRESSURE | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1989-07-25 | — | — | US | disclosed |
| US-4771049-A | REDUCING INTRAOCULAR PRESSURE | HOECHST-ROUSSEL PHARMACEUTICALS (US) | 1988-09-13 | — | — | US | disclosed |
| US-4677103-A | REDUCING INTRAOCULAR PRESSURE | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1987-06-30 | — | — | US | disclosed |
| US-4639443-A | INTRAOCULAR PRESSURE REDUCTION | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1987-01-27 | — | — | US | disclosed |
| EP-0193132-A2 | Labdan-derivatives, a process for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1986-09-03 | — | — | EP | disclosed |